Receipt of and Spending on Cessation Medication Among US Adults With Employer-Sponsored Health Insurance, 2010 and 2017
Author(s) -
Sundar S. Shrestha,
Xin Xu,
Xu Wang,
Stephen Babb,
Brian S. Armour,
Brian A. King,
Katrina F. Trivers
Publication year - 2021
Publication title -
public health reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.202
H-Index - 92
eISSN - 1468-2877
pISSN - 0033-3549
DOI - 10.1177/0033354920984155
Subject(s) - receipt , medicine , smoking cessation , pharmacy , residence , health insurance , demography , environmental health , family medicine , health care , business , accounting , pathology , sociology , economics , economic growth
Studies examining the use of smoking cessation treatment and related spending among enrollees with employer-sponsored health insurance are dated and limited in scope. We assessed changes in annual receipt of and spending on cessation medications approved by the US Food and Drug Administration (FDA) among tobacco users with employer-sponsored health insurance from 2010 to 2017.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom